Data Explorer

Research historical outbreak investigations and the full recall archive, with charts, trends, and advanced filters. Looking for what's happening right now instead? See current Health Alerts.

Recall totals

All FDA and USDA recalls in Public Health Trace, June 2012 to September 2026.

37,118

Total recall recordsAll FDA and USDA recalls in Public Health Trace

9,793

Class I recallsReasonable probability of serious health consequences

24,343

Class II recallsTemporary or medically reversible health consequences

2,887

Class III recallsNot likely to cause adverse health consequences

Quick insights

A snapshot of the most notable patterns across all recorded FDA and USDA recalls.

Most recalled product100 vegetarian Fenugreek Capsules 90 count, 600mg, packaged in 150cc Amber Glass Packer with White Polypropylene Cap. 53 recalls

Most common hazardLack of Assurance of Sterility 2,072 recalls

Newest recallhttp://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/gf-blends-recalls-truly-aip-all-purpose-flour-and-bread-mix-and-eat-gangster-flat-bread-pizza-mixPublished September 18, 2026

Most affected stateHawaii 200 recalls mention this state

State: ND ×
Clear all

Download matching recalls as CSV

CSV exports include up to 5,000 matching rows (applying your current filters), not the full dataset if it's larger.

Filters

Timeline Classification Table

Metric

Time range

Group by

View

Recalls announced by month (Year to date)

Download CSV

Source: FDA and USDA public dataLast updated September 22, 2026 ET

Summary (Year to date)

1,527 recalls have been announced year to date.
Aug 2026 was 24% lower than the previous complete period (Jul 2026: 240).
The highest complete period was Jun 2026 (297).
Sep 2026 is incomplete and not included in the figures above.

Complete data
Incomplete

Recalls by class

Recalls by class
Class	Recalls
Class II	24,343
Class I	9,793
Class III	2,887
Not Yet Classified	1

Download CSV

Recalls by class
Class	Recalls
Class II	24,343
Class I	9,793
Class III	2,887
Not Yet Classified	1

FDA Recall Terminated Historical recordClass II

Magnesium Sulfate in Water for Injection (0.325 mEq Mg++/mL) 40 mg/mL, 20 g Total, 500 mL Single-Dose Container bag, Rx only, Hospira, Inc. Lake Forest, IL 60045 USA, NDC 0409-6729-03.

by Pfizer Inc.

Reason: Correct Labeled Product Mispack: confirmed report involving a single unit of properly labeled Heparin in 0.45% Sodium Chloride for Injection (NDC 0409-7651-03, Lot 87903FW) that was found inside a case of Magnesium Sulfate in Water for Injection.
Published: October 17, 2018
Distribution: Nationwide

View recall →

FDA Recall Terminated Historical recordClass III

Amlodipine Besylate USP 10 mg Tablets, 1000-count bottles, Rx Only, Manufactured by: Cipla Ltd., Verna Goa, India, Manufactured for: Cipla USA, Inc. 1560 Sawgrass Corporate Parkway, Suite 130, Sunrise FL 33323 UPC 369097128159, NDC 69097-128-15

by InvaGen Pharmaceuticals, Inc.

Reason: Subpotent Drug: One lot of product does not meet the product specification for Assay test at 3 month long term stability condition.
Published: October 17, 2018
Distribution: Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

Pantoprazole Sodium Delayed-Release Tablets, USP, 40 mg*, 90-count bottle, Rx only, Manufactured by: Jubilant Generics Ltd., Roorkee - 247661, India; Marketed by: Jubilant Cadista Pharmaceuticals Inc., Salisbury, MD 21801; NDC 59746-284-90.

by Jubilant Cadista Pharmaceuticals, Inc.

Reason: Discoloration: Presence of dark discoloration or brown spots on the edges of the tablets.
Published: October 17, 2018
Distribution: Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

Glipizide XL (glipizide) extended-release tablets 5 mg 500-tablet bottle, Rx only Distributed by: Greenstone LLC. Peapack, NJ 07977 --- NDC 59762-0541-2

by Pfizer Inc.

Reason: CGMP Deviations; rejected product was used to manufacture final bulk lot
Published: October 17, 2018
Distribution: Nationwide

View recall →

FDA Recall United States Terminated Historical recordClass II

Sarap Asian Fusion

Product: Ube Cookies & Cream (cookies); A Sarap Asian Fusion Product…
Reason: Undeclared wheat, soy lecithin, and milk
Published: October 17, 2018
Distribution: Online to customers in AE, AK, AL, AR, A…

View recall →

FDA Recall United States Terminated Historical recordClass II

Sarap Asian Fusion

Product: Matcha Chocolate (cookies); A Sarap Asian Fusion Product;…
Reason: Undeclared wheat and soy lecithin
Published: October 17, 2018
Distribution: Online to customers in AE, AK, AL, AR, A…

View recall →

FDA Recall United States Terminated Historical recordClass II

Sarap Asian Fusion

Product: Black Sesame White Chocolate (cookies); A Sarap Asian Fusio…
Reason: Undeclared wheat, soy lecithin, and milk
Published: October 17, 2018
Distribution: Online to customers in AE, AK, AL, AR, A…

View recall →

FDA Recall United States Terminated Historical recordClass II

Sarap Asian Fusion

Product: Miso Milo Chocolate (cookies); A Sarap Asian Fusion Product…
Reason: Undeclared wheat and soy lecithin
Published: October 17, 2018
Distribution: Online to customers in AE, AK, AL, AR, A…

View recall →

FDA Recall United States Terminated Historical recordClass II

WHOLE FOODS MARKET

Product: 365 Everyday Value Brand White Corn Chips, Salted NET WT 20…
Reason: Product may contain undeclared milk.
Published: October 17, 2018
Distribution: Nationwide

View recall →

FDA Recall Terminated Historical recordClass III

treatNOW ABILIFY (aripiprazole) / ABILIFY MAINTENA 400-mg (aripiprazole) for extended release injectable suspension. Kit contents 2 packs Abilify Tablets 10 mg (14 day supply) plus 1 Abilfy Maintena Vial Kit.Rx only. Distributed and Marketed by: Otsuka America Pharmaceutical, Inc. Rockville, MD 20850 USA Marketed by: Lundbleck, Deerfield, IL 60015 USA Bar Code VialKit-59148-10Tabs-02

by Otsuka Pharmaceutical Development & Commercialization, Inc.

Reason: Labeling Not Elsewhere Classified: Physician sample kits/cartons of treatNOW Abilify are mislabeled. Product name is misspelled, storage instructions are missing and contents of kits may be incorrectly labeled on the outer packaging of the co-packaged kit.
Published: October 10, 2018
Distribution: Nationwide

View recall →

FDA Recall Terminated Historical recordClass III

treatNOW ABILIFY (aripiprazole) and ABILIFY MAINTENA (aripiprazole) 400MG for extended release injectable suspension. Kit Contents: 2 packs ABILIFY Tablets 10mg (14 day supply) plus 1 ABILIFY MAINTENA Pre-filled Dual Chamber Syringe Kit. Rx only. Not for sale or reimbursement. Distributed and Marketed by: Otsuka America Pharmaceutical, Inc. Rockville, MD 20850. Marketed by: Deerfield, IL 60015 USA. Bar Code DCSKit-59148-10Tabs-01

by Otsuka Pharmaceutical Development & Commercialization, Inc.

Reason: Labeling Not Elsewhere Classified: Physician sample kits/cartons of treatNOW Abilify are mislabeled. Product name is misspelled, storage instructions are missing and contents of kits may be incorrectly labeled on the outer packaging of the co-packaged kit.
Published: October 10, 2018
Distribution: Nationwide

View recall →

FDA Recall Terminated Historical recordClass I

robaxin-750 (methocarbamol tablets, USP), 750 mg, 100-count bottle, Rx Only, Distributed by: Endo Pharmaceuticals Inc., Malvern, PA 19355; Manufactured by: Kremers Urban Pharmaceuticals Inc., a subsidiary of Lannett Company, Inc., Seymour, IN 47274; NDC 52244-449-10.

by Endo Pharmaceuticals, Inc.

Reason: Labeling: Incorrect Instructions: Dosage information on the immediate container label incorrectly states "Two to four tablets four times daily." rather than the correct dosage of "Two tablets three times daily."
Published: October 10, 2018
Distribution: Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

Nystatin and Triamcinolone Acetonide Cream, USP, 100,000 units/gm & 1 mg/gm, packaged in a) 15 g tube (NDC 43598-431-44), b) 30 g tube (NDC 43598-431-30), c) 60 g tube (NDC 43598-431-60), Rx only, Distributor: Dr. Reddy's Laboratories, Inc. 107 College Road East, Princeton, NJ - 08540 Rx Only Made in India

by Dr. Reddy's Laboratories, Inc.

Reason: Failed stability specifications - An out of specification result was observed for the test parameter : composition of Nystatin during stability testing.
Published: October 10, 2018
Distribution: Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

Thyroid Powder 25kg/drum, US Pharmacopoeia, Sichuan Friendly Pharmaceutical Co., LTD, Production Address: No. 680, Hongpai Road, Dongxing District, Neijiang City Sichuan, China Tel:+886 832 2240082/2240298. NDC 7807-0170-11

by Sichuan Friendly Pharmaceutical Co.,Ltd.

Reason: CGMP Deviations: Thyroid Powder has inconsistent levels of the active ingredients levothyroxine and liothyronine.
Published: October 10, 2018
Distribution: Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

Elelyso (taliglucerase alfa) for injection, 200 units/vial, single-use vial, Rx only, Distributed by Pfizer Labs, Division of Pfizer Inc, NY, NY 10017, NDC 0069-0106-01

by Pfizer Inc.

Reason: Lack of assurance of sterility -Reports of loose metal ferrule crimps on vials for injection. The entire cap either lifted or dislodged while attempting to flip off the orange color plastic button.
Published: October 10, 2018
Distribution: Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

NeoRelief for Muscle Cramping & Restlessness Homeopathic Topical Gel, packaged in a) 4 ml sample packs and b) Net Wt. 2.0 oz (56.7g) bottles, BioLyte Laboratories - Grand Rapids, MI 49534, NDC 58368-002-02

by BioLyte Laboratories, LLC

Reason: CGMP Deviations: finished product produced with active ingredients recalled by the manufacturer, King Bio Inc., due to water contamination issues that could potentially affect the quality of this product.
Published: October 10, 2018
Distribution: Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

Clozapine Orally Disintegrating Tablets, 12.5 mg, 100-count bottles, Rx only, Teva Pharmaceuticals USA, Inc., North Wales, PA 19454, NDC 0093-5416-01 Yellow, round, flat-faced, beveled-edge, unscored tablet. Debossed with 13 on one side and plain on the other side.

by Teva Pharmaceuticals USA

Reason: Failed Disintegration Specifications: Out-of-specification disintegration test result obtained during routine stability testing.
Published: October 10, 2018
Distribution: Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

Synjardy (empagliflozin and metformin hydrochloride) Tablets. 5 mg/1000 mg. Rx only. 180-count bottle. Distributed by: Boehinger Ingelheim (BI) Pharmaceuticals, Inc. Ridgefield, CT 06877. Made in Germany. Marketed by: BI Pharmaceuticals, Inc. Ridgefield, CT 06877 and Eli Lilly and Company Indianapolis IN 46285 NDC 0597-0175-18

by Boehringer Ingelheim Pharmaceuticals, Inc.

Reason: Cross Contamination With Other Products:
Published: October 3, 2018
Distribution: Nationwide

View recall →

FDA Recall Terminated Historical recordClass III

Levofloxacin Injection in 5% Dextrose, 5 mg/mL, packaged in a) 50 mL (NDC 36000-046-24), b) 100 mL (NDC 36000-047-24), c) 150 mL (NDC 36000-048-24) Container bags, Rx only, Manufactured for: Claris Lifesciences Inc., North Brunswick, NJ 08902; By: Claris Injectables Ltd., Gujarat, India.

by Baxter Healthcare Corporation

Reason: Superpotent Drug: High out of specification results for levofloxacin resulting in increased concentration of solution.
Published: October 3, 2018
Distribution: Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

Montelukast Sodium Tablets, 10 mg*, 30-count bottles, Rx Only, By: Hetero, Hetero Labs Limited, Unit V, Polepally, Jadcherla, Mahaboob Nagar - 509 301, India, Manufactured for: Camber Pharmaceuticals, Inc., Piscataway, NJ 08854, NDC 31722-726-30.

by Hetero Labs Limited Unit V

Reason: Discoloration: A complaint was received from a pharmacist for the presence of blue specks on tablets.
Published: October 3, 2018
Distribution: Nationwide

View recall →

Data last updated: September 22, 2026 ET

Recall records are summarized from official FDA and USDA sources. Notices may be updated, reclassified, terminated, or withdrawn. Always review the linked official notice for the most current instructions. Read the full medical disclaimer.